Modulation of glucose uptake in rat's brain, heart, liver and kidneys, after administration of quinpirole and 7-OH-DPAT, two central dopamine-D 3 receptor agonists

Pharmacology Reviews and Communications

Volumn 10, Issue 4, 1999, Pages 321-328

  Szkilnik, Ryszard ^a   Oswiecimska, Joanna ^a   Brus, Ryszard ^a   Konecki, Janusz ^a   Karasinska, Agata ^a   Shani, Jashovam ^b,c  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

7 OH DPAT; Dopamine receptors; Glucose uptake; Heart glucose; Kidney glucose; Liver glucose; Quinpirole; Rat brain

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; GLUCOSE; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART; ISOTOPE LABELING; LIVER; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033384013     PISSN: 10288945     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bittar, M.L., Koulu, M., Rapport S. and Linnoila, M. (1986) Diabetes-induced alteration in brain monoamine metabolism in rats. J. Pharmacol. Exp. Ther. 236,432-437.
2. Branon, E.P. and Graham, W.L. (1955) Intensive insulin shock therapy, a five-year survey. Amer. J. Psychiatry 111,659-663.
3. 1 dopamine receptors in neonatally-lesioned rats. J. Pharmacol. Exp. Ther. 234,447-455.
4. Brus, R., Szkilnik, R., Kostrzewa, R.M., Jedrusiak, I., Konecki, J., Glowacka, M. and Shani, J. (1995) Modulation of glucose uptake in rat brain after administration of quinpirole and SKF-38393, two central dopamine-receptor agonists. Pharmacol. Comm. 7,87-91.
5. Chance, W.T., Cao, L. and Fischer, J.E. (1989) Brain 3-methoxytyramine varies inversely with blood glucose in decapitated rats. Pharmacol. Biochem. Behav. 32,553-556.
6. Creese, I., Burt, D.R. and Snyder, S.H (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of anti-schizophrenic drugs. Science 192,481-483.
7. 2receptors. Psychopharmacology 106,447-454.
8. Kebabian, J.W., Calne, D.B. (1979) Multiple receptors for dopamine. Nature 277,93-96.
9. Kostrzewa, R M. and Brus, R. (1991) Ontogenetic homologous supersensitization of quinpirole-induced yawning in rats. Pharmacol. Biochem. Behav. 39,517-519.
10. Kostrzewa, R.M., Brus, R., Rykaczewska, M. and Plech, A. (1993) Low-dose quinpirole ontogenetically sensitizes to quinpirole-induced yawning in rats. Pharmacol. Biochem. Behav. 44,487-489.
11. 3 receptor binding affinities. Eur. J. Pharmacol. 277,209-214.
12. 3 receptor agonists, 7-OH-DPAT and quinpirole on yawning, stereotypy and body temperature in rats. Pharmacol. Biochem. Behav. 52,503-508.
13. 3 receptor sites in the brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur J. Neurosci. 5,145-153.
14. 3H)-hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA 89,8155-8159.
15. Lezovsky, D.B., Kopin, I.J. and Sailer, C.F. (1985) Modulation of dopamine-receptor supersensitivity by chronic indulin, implication in schizophrenia. Brain Res. 343, 190-193.
16. McCaleb, M.I. and Myers, R.D. (1979) Striatal dopamine release is altered by glucose and insulin during push-pull perfusion on the rat's caudate nucleus. Brain Res. Bull. 4,651-656.
17. Meyer, ME. (1996) Mesolimbic 7-OH-DPAT affects locomotor activities in rats. Pharmacol. Biochem. Behav. 55,209-214.
18. Montefusco, O, Assini, M.C. and Missale, C. (1983) Insulin-mediated effects of glucose on dopamine metabolism. Acta Diabetol. Lat. 20,71-77.
19. 1 receptor stimulation by 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist. Synapse 13,264-269.
20. 2 receptors to mesostraiatal regions of human forebrain. Proc. Natl Acad. Sci. USA 91,11271-11275.
21. Oswiecimska, J., Sokola, A. and Brus, R. (1998) Comparison of some central effects of two dopamine agonists, quinpirole and 7-OH-DPAT, in rats, Pol. J. Pharmacol. 50,173-174.
22. Oswiecimska, J., Brus, R., Szkilnik, R. and Kostrzewa, R.M. (1999) Quinpirole, not 7-OH-DPAT, produces homologous ontogenetic priming of yawning behavior in rats. Pharmacol. Biochem. Behav. (submitted).
23. Saller, S.F. (1984) Dopaminergic activity is reduced in diabetic rats. Neurosci. Lett. 49,301-306.
24. Sailer, C.F. and Kreamer, L.D. (1991) Glucose concentration in brain and blood: regulation by dopamine receptor subtypes. Brain Res. 546,235-240.
25. Sauter, A., Goldstein, M., Engel, J. and Ueta, K. (1983) Effect of insulin on central catecholamines. Brain Res. 260,330-333.
26. 3 as a target for neuroleptics. Nature 347,146-151.
27. 2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxytryptamine substntia nigra lesions. J. Neurosci. 7,2927-2935.
28. Unvans-Moberg, K, Ahlenius, S., Alster, P. and Hillegaart, V (1996) Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat. Neuroendocrinology 63,269-274.
29. White, N.M. and Blackburn, J. (1986) Effect of glucose on amphetamine-induced motor behavior. Life Sci. 38,2255-2258.
30. Wiesel, F.A., Wik, G., Sjogren, I., Blomquist, G. and Green, T. (1987) Altered relationship between metabolic rates of glucose in brain regions of schizophrenic patients. Acta Psychiatr Scan. 76,642-647.